Welcome to the CHolinesterase Inhibitors to prEvent Falls in Parkinson’s Disease (CHIEF-PD) Trial. This is medical research trial that is examining whether drugs that are used normally to treat people with memory and thinking problems can be used to reduce the number of falls people with Parkinson’s experience.
The trial is currently being set up and will be ready to start recruiting patients in mid 2019. We need to enrol 600 people with Parkinson’s who have experienced a fall (in the year before they join the trial) across about 26 NHS hospital sites in the UK.
We would welcome hearing from you and have opportunities for patients to take part, be involved in the design of the research, receive our newsletter, or for health professionals to work in our central trial team.
We will post updates on this website so please check back regularly or you can follow progress on twitter.
For more info, please read our latest newsletter.